Author

E. Batourina

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

C. L. Mendelsohn· 2 shared C. Lu· 2 shared J. M. Mckiernan· 2 shared T. Tate· 2 shared X. Chen· 2 shared A. D. Viny· 1 shared A. Molotkov· 1 shared B. Alija· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. L. Mendelsohn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combined Mek inhibition and Pparg activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis

T. Tate, S. A. Plumber, H. Al-Ahmadie, X. Chen, W. Choi, C. Lu, A. D. Viny, E. Batourina, K. Gretarsson, B. Alija, A. Molotkov, G. Wiessner, J. M. Mckiernan, D. J. McConkey, C. Dinney, , C. L. Mendelsohn

This study shows that combining MEK inhibition and Pparg activation eradicates muscle-invasive bladder cancer in a mouse model by reversing tumor differentiation and inducing apoptosis.

bioRxiv · Aug 19, 2023 · PreprintCancer Biology

Pparg drives luminal differentiation and luminal tumor formation in the urothelium

T. Tate, T. Xiang, M. Zhou, W. Y. Kim, X. Chen, H. Kim, E. Batourina, C.-S. Lin, C. Lu, S. E. Wobker, J. M. Mckiernan, C. L. Mendelsohn

This study shows that Pparg promotes luminal differentiation and tumor formation in urothelial cells, with tumors showing immune desertion and potential subtype shifts over time.

Nature Communications · Oct 25, 2021Peer-reviewedCancer Biology